2077-8333

Epilepsy and Paroxysmal Conditions

IRBIS

View prefix report (10.17749)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 147 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact147 DOIs
2

Add abstracts to 140 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact140 DOIs
3

Add license metadata to 117 records

License metadata tells indexers and readers how each article may be reused.

Medium impact117 DOIs

DOIs for this ISSN

Showing the top 5 of 372 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 ILAE CLASSIFICATION OF THE EPILEPSIES: THE 2017 REVISION AND… (10.17749/2077-8333.2017.9.1.006-025)
Abstract References ORCID License
169.90 49
2 THE CONCEPT OF THE “EPILEPTIC SYSTEM” IS CREDITED TO RUSSIAN… (10.17749/2077-8333.2017.9.4.076-085)
Abstract References ORCID License
104.14 10
3 ADVERSE EFFECTS OF ANTIEPILEPTIC DRUGS (10.17749/2077-8333.2017.9.1.051-061)
Abstract References ORCID License
100.00 9
4 NON EPILEPTIC PAROXYSMAL EVENTS IMITATING EPILEPSY IN CHILDR… (10.17749/2077-8333.2016.8.4.023-033)
Abstract References ORCID License
95.42 8
5 4-BENZOYLPYRIDINE OXIME DERIVATIVE (GIZH-298) VERSUS VALPROI… (10.17749/2077-8333.2017.9.2.057-066)
Abstract References ORCID License
95.42 8
6 NOVEL PYRIMIDINE DERIVATIVES WITH ANTICONVULSANT AND PSYCHOT… (10.17749/2077-8333.2017.9.3.040-046)
Abstract References ORCID License
90.31 7
7 CLINICAL AND GENETIC HETEROGENITY OF JUVENILE MYOCLONIC EPIL… (10.17749/2077-8333.2016.8.2.020-036)
Abstract References ORCID License
84.51 6
8 IMPACT OF ANTIEPILEPTIC DRUGS ON COGNITIVE FUNCTIONS: FOCUS… (10.17749/2077-8333.2016.8.3.006-010)
Abstract References ORCID License
84.51 6
9 SLEEP DISORDERS IN EPILEPTIC PATIENTS (10.17749/2077-8333.2017.9.1.036-039)
Abstract References ORCID License
84.51 6
10 NEURODEVELOPMENTAL DISORDERS IN CHILDREN WITH EPILEPSY (10.17749/2077-8333.2016.8.1.050-054)
Abstract References ORCID License
77.82 5
11 THE DIAGNOSTIC VALUE OF EEG AND BIOCHEMICAL MARKERS OF BRAIN… (10.17749/2077-8333.2016.8.4.091-098)
Abstract References ORCID License
77.82 5
12 SURGICAL TREATMENT OF TEMPORAL EPILEPSIA: PROBLEMS AND EFFEC… (10.17749/2077-8333.2017.9.2.041-049)
Abstract References ORCID License
77.82 5
13 EPILEPTIC ENCEPHALOPATHIES WITH ELECTRICAL STATUS EPILEPTICU… (10.17749/2077-8333.2018.10.1.063-071)
Abstract References ORCID License
77.82 5
14 DIAGNOSTICS AND LONG-TERM OUTCOMES AFTER SURGICAL TREA… (10.17749/2077-8333.2017.9.1.040-050)
Abstract References ORCID License
69.90 4
15 TRANSFORMATION OF THE EPILEPTIC SYSTEM. CURRENT STATUS OF TH… (10.17749/2077-8333.2017.9.2.006-019)
Abstract References ORCID License
69.90 4
16 ALPERS-HUTTENLOCHER SYNDROME (10.17749/2077-8333.2015.7.1.046-055)
Abstract References ORCID License
60.21 3
17 EFFICACY AND SAFETY OF LEVETIRACETAM IN CHILDREN WITH ELECTR… (10.17749/2077-8333.2017.9.2.021-028)
Abstract References ORCID License
60.21 3
18 PATHOLOGICAL SIGNS OF EPILEPTIC AND NON-EPILEPTIC ORIGIN DET… (10.17749/2077-8333.2017.9.2.030-040)
Abstract References ORCID License
60.21 3
19 DEPRESSIONS IN EPILEPSIA: PREVALENCE, RISK FACTORS, SYMPTOMS… (10.17749/2077-8333.2017.9.3.047-053)
Abstract References ORCID License
60.21 3
20 NEURODEVELOPMENTAL DISORDERS IN CHILDREN WITH EPILEPSY: INTE… (10.17749/2077-8333.2017.9.4.064-071)
Abstract References ORCID License
60.21 3
21 NON-INVASIVE ASSESSMENT OF ANTI-SEIZURE DRUGS AND THEIR ABIL… (10.17749/2077-8333.2017.9.4.086-095)
Abstract References ORCID License
60.21 3
22 MUSICOGENIC EPILEPSY. A REVIEW OF THE LITERATURE AND A CASE… (10.17749/2077-8333.2018.10.1.025-034)
Abstract References ORCID License
60.21 3
23 MODERN TREATMENT OF DRUG-RESISTANT EPILEPSY, AVAILABLE IN RU… (10.17749/2077-8333.2016.8.1.022-028)
Abstract References ORCID License
47.71 2
24 EPILEPSY AT ADULTS: GENDER COMORBIDE DISORDERS, APPLICATION… (10.17749/2077-8333.2016.8.1.043-049)
Abstract References ORCID License
47.71 2
25 EPILEPSY IN INBORN ERRORS OF METABOLISM (10.17749/2077-8333.2016.8.1.055-061)
Abstract References ORCID License
47.71 2
26 EPILEPTIC ENCEPHALOPTHIES WITH ELECTRICAL STATUS EPILEPTICUS… (10.17749/2077-8333.2016.8.1.062-065)
Abstract References ORCID License
47.71 2
27 COMPARATIVE ANTICONVULSANT AND ANTIHYPOXIC EFFECTS OF ASTROK… (10.17749/2077-8333.2016.8.1.075-082)
Abstract References ORCID License
47.71 2
28 THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS… (10.17749/2077-8333.2016.8.3.011-018)
Abstract References ORCID License
47.71 2
29 THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIE… (10.17749/2077-8333.2016.8.3.066-073)
Abstract References ORCID License
47.71 2
30 EVOKED POTENTIALS IN CHILDREN WITH PAROXYSMAL DISORDERS (10.17749/2077-8333.2017.9.2.067-073)
Abstract References ORCID License
47.71 2
31 USE OF VALPROIC ACID IN WOMEN WITH EPILEPSY DURING PREGNANCY (10.17749/2077-8333.2017.9.3.022-031)
Abstract References ORCID License
47.71 2
32 TREATMENT OF EPILEPSY IN PATIENTS OF “VU LNERABLE” AGE: THE… (10.17749/2077-8333.2017.9.3.032-038)
Abstract References ORCID License
47.71 2
33 EPILEPSY WITH GELASTIC SEIZURES AND HYPOTHALAMIC HAMARTOMA:… (10.17749/2077-8333.2017.9.3.064-072)
Abstract References ORCID License
47.71 2
34 MICROSTRUCTURAL AND FUNCTIONAL ABNORMALITIES IN THE BRAIN OF… (10.17749/2077-8333.2017.9.4.041-049)
Abstract References ORCID License
47.71 2
35 Neurophysiological parameters and the tone of the autonomic… (10.17749/2077-8333.2018.10.2.026-034)
ORCID License
38.91 5
36 Today’s choice of antiepileptic therapy: stages and recommen… (10.17749/2077-8333.2018.10.2.074-081)
ORCID License
38.91 5
37 EFFECTS OF LEVETINOL ON EPILEPTIFORM ACTIVITY OF THE BRAIN I… (10.17749/2077-8333.2018.10.1.052-062)
Abstract References License
35.78 2
38 Role of contrast-free MR-perfusion in the diagnosis of poten… (10.17749/2077-8333.2018.10.2.006-018)
ORCID License
34.95 4
39 Is there a universal drug for epilepsy? (10.17749/2077-8333.2018.10.2.095-103)
ORCID License
34.95 4
40 SEVERE EPILEPTIC ENCEPHALOPATHY OF EARLY CHILDHOOD DUE TO SC… (10.17749/2077-8333.2015.7.1.035-040)
Abstract References ORCID License
30.10 1
41 EEG AND EVENT-RELATED POTENTIAL (P300) IN ELDERLY PATIENTS W… (10.17749/2077-8333.2016.8.1.012-021)
Abstract References ORCID License
30.10 1
42 NEUROPHYSIOLOGICAL AND PSYCHOPATHOLOGICAL ASPECTS OF EPILEPS… (10.17749/2077-8333.2016.8.1.029-036)
Abstract References ORCID License
30.10 1
43 EFFECT OF KETOGENIC DIET ON COGNITIVE AND MOTOR FUNCTIONS IN… (10.17749/2077-8333.2016.8.1.037-042)
Abstract References ORCID License
30.10 1
44 VIDEO-EEG-MONITORING IN DIAGNOSIS OF MYOCLONIC ABSENCES (10.17749/2077-8333.2016.8.1.066-074)
Abstract References ORCID License
30.10 1
45 THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTI… (10.17749/2077-8333.2016.8.2.006-013)
Abstract References ORCID License
30.10 1
46 ELECTROPHYSIOLOGICAL AND NEUROCHEMICAL STUDIES OF THE MECHA… (10.17749/2077-8333.2016.8.3.019-026)
Abstract References ORCID License
30.10 1
47 FREQUENCY OF CLINICAL PHENOTYPES OF JUVENILE MYOCLONIC EPI… (10.17749/2077-8333.2016.8.3.027-033)
Abstract References ORCID License
30.10 1
48 THE CHOICE OF ANTIDEPRESSANTS FOR THE TREATMENT OF DEPRESSI… (10.17749/2077-8333.2016.8.3.034-044)
Abstract References ORCID License
30.10 1
49 POSSIBILITIES OF TIC HYPERKINESIA THERAPY USING ANTIСONVULSA… (10.17749/2077-8333.2016.8.3.045-051)
Abstract References ORCID License
30.10 1
50 EPILEPSY ASSOCIATED WITH EPILEPTIC EYELID MYOCLONIA WITH OR… (10.17749/2077-8333.2016.8.3.052-062)
Abstract References ORCID License
30.10 1